Ling Hu
Impact in
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
Papers in
-
- Genomics, phytochemicals, and oxidative stress 5
- Gut microbiota and health 2
- Heme Oxygenase-1 and Carbon Monoxide 2
- Peroxisome Proliferator-Activated Receptors 2
-
- Chemotherapy-induced organ toxicity mitigation 2
- Co-authors
- Liang Yin (2 shared papers)Gu Gong (2 shared papers)Libang Yuan (2 shared papers)Wei Wu (2 shared papers)Hongyue Yu (1 shared paper)Xinhua Xiao (1 shared paper)Qian Zhang (1 shared paper)Fengjiao Xin (1 shared paper)
- Journals
- Biomedicine & Pharmacotherapy (2 papers)Acta Pharmacologica Sinica (2 papers)Molecules (2 papers)Journal of Neuroimmunology (1 paper)Frontiers in Nutrition (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Ling Hu
36 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 97
- Clinical Biochemistry 92
- Pharmacology 102
- Neurology 90
- Biological Psychiatry 26
- Cancer Research 123
Countries citing papers authored by Ling Hu
This map shows the geographic impact of Ling Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Hu more than expected).
Fields of papers citing papers by Ling Hu
This network shows the impact of papers produced by Ling Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Hu. The network helps show where Ling Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 159 | |
| 2 | 2018 | 154 | |
| 3 | 2016 | 113 | |
| 4 | 2011 | 86 | |
| 5 | 2021 | 53 | |
| 6 | 2019 | 49 | |
| 7 | 2019 | 47 | |
| 8 | 2021 | 44 | |
| 9 | 2020 | 43 | |
| 10 | 2021 | 30 | |
| 11 | 2021 | 24 | |
| 12 | 2018 | 24 | |
| 13 | 2020 | 24 | |
| 14 | 2021 | 21 | |
| 15 | 2020 | 20 | |
| 16 | 2009 | 20 | |
| 17 | 2021 | 16 | |
| 18 | 2023 | 15 | |
| 19 | 2014 | 14 | |
| 20 | 2021 | 14 |
About Ling Hu
Ling Hu is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Physiology, Immunology and Cancer Research, having authored 37 papers that have together received 1.1k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (5 papers), MicroRNA in disease regulation (3 papers), Gut microbiota and health (2 papers), Antioxidants, Aging, Portulaca oleracea (2 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Chemotherapy-induced organ toxicity mitigation (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Clinical Biochemistry (92 citations), Pharmacology (102 citations), Neurology (90 citations), Biological Psychiatry (26 citations) and Cancer Research (123 citations). Ling Hu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Liang Yin, Gu Gong, Libang Yuan, Wei Wu, Hongyue Yu, Xinhua Xiao, Qian Zhang, Fengjiao Xin, Lin Cai and Hailong Dong. Their work appears in journals such as Biomedicine & Pharmacotherapy, Acta Pharmacologica Sinica, Molecules, Journal of Neuroimmunology and Frontiers in Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.